跳至主要内容
临床试验/CTRI/2023/08/057051
CTRI/2023/08/057051招募中3 期

ow dose inhaled corticosteroids (ICS) plus long-acting beta-2 agonist (LABA) as needed compared to daily low dose ICS or montelukast in children with mild asthma: a randomized controlled trial - NI

Rashmi Ranjan Das0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Mild asthma or requiring Step 2 asthma treatment as per GINA 2023 guideline

排除标准

  • 1) History of hospitalization for =24 hrs for asthma in past 12 months
  • 2) History of life threatening asthma requiring intensive care unit (ICU) admission
  • 3) Use of ICS or LABA or Montelukast or sustained release Theophylline in past 6 months
  • 4) History of known hypersensitivity or contraindication to any above drugs used
  • 5) Behavioral or neuropsychiatry disorder
  • 6) Use of systemic steroids in last 6 weeks
  • 7) Unwilling to change the current asthma treatment

研究者

发起方
Rashmi Ranjan Das

相似试验